Evidence map›Paper›PMID 42348774›Full record

ArticleJournal of neuromuscular diseases2026

Facilitators and barriers to exercise in autoimmune myasthenia gravis: A cross-sectional survey study.

Simone Birnbaum, Annie Archer, Julie Lejeune, Jean-Yves Hogrel, Caroline Stalens

Abstract read
In one paragraph

Article in Journal of neuromuscular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Simone BirnbaumNeuromuscular Investigation Center, Neuromuscular Physiology and Evaluation Laboratory, Groupe Hospitalier Pitié Salpêtrière, Institute of Myology, Paris, France.ORCID 0000-0003-2358-788X
Annie ArcherPatient expert and representative advocacy and support group myasthenic syndromes, AFM-Téléthon, Evry, France.
Julie LejeuneDirection des Opérations et Innovations Scientifiques (DO.IS), Département Data Santé et Recherche Médicale (DSRM), AFM-Téléthon, Evry, France.
Jean-Yves HogrelNeuromuscular Investigation Center, Neuromuscular Physiology and Evaluation Laboratory, Groupe Hospitalier Pitié Salpêtrière, Institute of Myology, Paris, France.
Caroline StalensDirection des Opérations et Innovations Scientifiques (DO.IS), Département Data Santé et Recherche Médicale (DSRM), AFM-Téléthon, Evry, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionKnowledge about facilitators and barriers to exercise among individuals with MG is limited.ObjectiveThe aim of this study was to identify factors that influence exercise participation for adults with MG and to explore beliefs and perceptions with respect to exercise.MethodsThis was a cross-sectional observational study via an online questionnaire. Adults with MG residing in France were eligible.ResultsResponses from 455 participants were analysed. The majority were between 50 and 69 years, 71% were female, 80% had generalised MG, and half had early-onset MG. Participants reported reduced MG-specific QoL (MGQOL-15F-r), a moderate-to-high impact of MG on activities of daily living (MG-ADL), and mild-to-moderate fatigue levels (NeuroQoL fatigue). Overall, 54% of respondents reported engaging in exercise ("exercisers"), while 47% did not ("non-exercisers"). Exercisers had a lower BMI, reported less fatigue, better HRQoL and a lower impact of MG on ADLs compared to non-exercisers. Fear of exercising was reported by one-third of participants, including half of non-exercisers versus 19% of exercisers (p < 0.001). Non-exercisers reported significantly more barriers to exercise (mean 3.5 (1.8)) than exercisers (mean 2.6 (1.9), p < 0.001). Health/symptoms was the most frequently reported barrier in both groups (59% of non-exercisers, 39% of exercisers). Non-exercisers also reported fewer facilitators (mean 2.1 (1.4)) than for exercisers (mean 2.5 (1.3), p=0.004). The most frequently cited facilitator for non-exercisers was specialised supervision/coaching (59%), while exercisers most frequently cited health/symptom improvement (57%).ConclusionSeveral barriers and facilitators influencing exercise participation for individuals with MG could be addressed with tailored programmes.

Indexed as

barriersbeliefsexercisefacilitatorsmyasthenia gravis

Identifiers

PMID42348774
PMCPMC13439003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.